您当前的位置:
首页 >
文章列表页 >
Research on Dihydrotanshinone Ⅰ Inhibiting Ovarian Cancer Progression Through Nuclear Factor Kappa B Signaling Pathway
更新时间:2022-10-08
    • Research on Dihydrotanshinone Ⅰ Inhibiting Ovarian Cancer Progression Through Nuclear Factor Kappa B Signaling Pathway

    • Vol. 20, Issue 6, Pages: 656-659(2020)
    • 作者机构:

      1. 广西壮族自治区南溪山医院妇科

      2. 广西医科大学附属肿瘤医院肿瘤妇科

      3. 桂林市人民医院妇科

    • DOI:10.14009/j.issn.1672-2124.2020.06.005    

      CLC: R285.5
    • Published:2020,

    扫 描 看 全 文

  • PENG Xiangyun, WANG He, WANG Lan, et al. Research on Dihydrotanshinone Ⅰ Inhibiting Ovarian Cancer Progression Through Nuclear Factor Kappa B Signaling Pathway. [J]. 20(6):656-659(2020) DOI: 10.14009/j.issn.1672-2124.2020.06.005.

  •  
  •  
查看原文

0

Views

58

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Synergistic Effects of Sijunzi Decoction Combined with Gefitinib on Non-Small Cell Lung Cancer PC9 Cells and Evaluation for Principle of Intermediate Effects
Effects of Tanshinone ⅡA Combined with Dexmetomidine in Regulating Autophagy Levels Against Renal Ischemia Reperfusion Injury by AMPK/ULK1 Pathway
Effects of Jiedu Xiao’ai Formula on Invasion,Migration and Epithelial Mesenchymal Transformation of Glioma Cells

Related Author

WANG Zhihong
WANG Shiyuan
CAO Bo
ZHANG Mingyu
LI Taifeng
LI Chunyu
LI Guohui
TANG Ting

Related Institution

Dept.of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Dept.of Anesthesiology and Surgry,Brain Hospital of Hunan
Dept. of Neurosurgery, Tumor Hospital Affiliated to Harbin Medical University
0